GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $169,000 | -91.1% | 780 | -95.3% | 0.00% | -100.0% |
| Q4 2020 | $1,907,000 | +105.7% | 16,530 | +73.5% | 0.00% | +100.0% |
| Q3 2020 | $927,000 | -21.0% | 9,527 | -0.3% | 0.00% | -33.3% |
| Q2 2020 | $1,173,000 | +40.1% | 9,560 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $837,000 | -31.6% | 9,560 | -18.4% | 0.00% | 0.0% |
| Q4 2019 | $1,224,000 | -9.7% | 11,710 | -0.7% | 0.00% | -25.0% |
| Q3 2019 | $1,356,000 | -33.7% | 11,792 | -0.6% | 0.00% | -33.3% |
| Q2 2019 | $2,045,000 | +3.9% | 11,858 | +1.5% | 0.01% | 0.0% |
| Q1 2019 | $1,969,000 | +74.1% | 11,683 | +0.6% | 0.01% | +50.0% |
| Q4 2018 | $1,131,000 | -42.6% | 11,608 | +1.8% | 0.00% | -33.3% |
| Q3 2018 | $1,969,000 | +26.0% | 11,400 | +1.8% | 0.01% | +20.0% |
| Q2 2018 | $1,563,000 | +18.9% | 11,200 | -4.1% | 0.01% | +25.0% |
| Q1 2018 | $1,315,000 | -16.8% | 11,675 | -2.5% | 0.00% | -20.0% |
| Q4 2017 | $1,581,000 | +29.6% | 11,973 | -0.4% | 0.01% | +25.0% |
| Q3 2017 | $1,220,000 | +1.2% | 12,023 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,205,000 | -17.4% | 12,023 | -0.2% | 0.00% | -20.0% |
| Q1 2017 | $1,458,000 | +8.6% | 12,050 | +0.2% | 0.01% | 0.0% |
| Q4 2016 | $1,343,000 | -15.5% | 12,022 | +0.3% | 0.01% | -16.7% |
| Q3 2016 | $1,590,000 | +47.9% | 11,983 | +2.0% | 0.01% | +50.0% |
| Q2 2016 | $1,075,000 | +26.9% | 11,748 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $847,000 | +3.8% | 11,748 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $816,000 | -24.1% | 11,748 | -0.1% | 0.00% | -40.0% |
| Q3 2015 | $1,075,000 | +173.5% | 11,757 | +267.6% | 0.01% | +150.0% |
| Q2 2015 | $393,000 | +35.1% | 3,198 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $291,000 | +34.7% | 3,198 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $216,000 | +440.0% | 3,198 | +548.7% | 0.00% | – |
| Q3 2014 | $40,000 | -4.8% | 493 | +25.4% | 0.00% | – |
| Q2 2014 | $42,000 | +82.6% | 393 | 0.0% | 0.00% | – |
| Q1 2014 | $23,000 | – | 393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |